Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare healthcare utilization and costs in asthma patients
who receive fluticasone propionate/salmeterol combination 100mcg/50mcg ("FSC 100/50") or
inhaled corticosteriods in typical clinical practice using a retrospective observational
cohort study design of large managed care database.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance